Cigna Corporation (NYSE:CI) has been assigned a consensus recommendation of “Buy” from the nineteen ratings firms that are presently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has given a strong buy rating to the company. The average 1-year target price among brokers that have issued a report on the stock in the last year is $182.06.

Several equities analysts have issued reports on the stock. UBS AG restated a “buy” rating and issued a $186.00 price objective (up previously from $181.00) on shares of Cigna Corporation in a research note on Monday, June 5th. Bank of America Corporation upped their price objective on shares of Cigna Corporation from $193.00 to $198.00 and gave the company a “buy” rating in a research note on Friday, June 23rd. Jefferies Group LLC restated a “buy” rating and issued a $183.00 price objective on shares of Cigna Corporation in a research note on Thursday, June 8th. ValuEngine downgraded shares of Cigna Corporation from a “buy” rating to a “hold” rating in a research note on Thursday, July 20th. Finally, Citigroup Inc. upped their price objective on shares of Cigna Corporation from $185.00 to $198.00 and gave the company a “buy” rating in a research note on Monday, August 7th.

Shares of Cigna Corporation (CI) traded up 0.44% during trading on Friday, reaching $186.05. The company had a trading volume of 2,462,011 shares. The firm has a 50-day moving average of $179.52 and a 200 day moving average of $165.10. The firm has a market capitalization of $46.84 billion, a PE ratio of 21.47 and a beta of 0.43. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $188.36.

Cigna Corporation (NYSE:CI) last released its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.48 by $0.43. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The company had revenue of $10.32 billion during the quarter, compared to the consensus estimate of $10.26 billion. During the same quarter in the prior year, the firm posted $1.98 earnings per share. Cigna Corporation’s revenue for the quarter was up 3.6% on a year-over-year basis. Analysts expect that Cigna Corporation will post $10.02 earnings per share for the current year.

In related news, CEO David Cordani sold 153,168 shares of the stock in a transaction dated Monday, June 19th. The shares were sold at an average price of $170.20, for a total transaction of $26,069,193.60. Following the completion of the transaction, the chief executive officer now directly owns 421,162 shares of the company’s stock, valued at $71,681,772.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director William D. Zollars sold 1,232 shares of the stock in a transaction dated Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total transaction of $230,667.36. The disclosure for this sale can be found here. Insiders have sold 223,821 shares of company stock valued at $38,506,877 over the last three months. 1.30% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of CI. Achmea Investment Management B.V. increased its holdings in Cigna Corporation by 73.7% in the second quarter. Achmea Investment Management B.V. now owns 18,365 shares of the health services provider’s stock valued at $3,073,000 after buying an additional 7,791 shares in the last quarter. Lord Abbett & CO. LLC increased its holdings in Cigna Corporation by 2.8% in the second quarter. Lord Abbett & CO. LLC now owns 43,600 shares of the health services provider’s stock valued at $7,298,000 after buying an additional 1,200 shares in the last quarter. Toronto Dominion Bank increased its holdings in Cigna Corporation by 25.0% in the second quarter. Toronto Dominion Bank now owns 86,740 shares of the health services provider’s stock valued at $14,517,000 after buying an additional 17,348 shares in the last quarter. Beaton Management Co. Inc. purchased a new position in Cigna Corporation in the second quarter valued at about $298,000. Finally, Dynamic Technology Lab Private Ltd increased its holdings in Cigna Corporation by 255.4% in the second quarter. Dynamic Technology Lab Private Ltd now owns 6,752 shares of the health services provider’s stock valued at $1,130,000 after buying an additional 4,852 shares in the last quarter. 87.96% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION WARNING: “Cigna Corporation (CI) Receives Average Recommendation of “Buy” from Analysts” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this news story on another site, it was stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this news story can be read at https://www.americanbankingnews.com/2017/09/16/cigna-corporation-ci-receives-average-recommendation-of-buy-from-analysts.html.

About Cigna Corporation

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Analyst Recommendations for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.